Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting PFKFB3 reduces the severity of colitis in mouse models

Feb. 18, 2022

New biomarkers identified to predict response to vedolizumab in patients with Crohn's disease

Feb. 18, 2022

Targeting GDNF may have potential to treat IBD

Feb. 18, 2022

Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis

Feb. 18, 2022

Using photoactivatable peptide toxins for modulation of voltage-gated ion channels

Feb. 18, 2022

Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody

Feb. 18, 2022

Neurophilin-1 is an inhibitor of HIV-1 infectivity

Feb. 18, 2022

New HSD17B13 inhibitors identified at Inipharm

Feb. 18, 2022

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

Feb. 18, 2022

New SREBP inhibitors identified at Capulus Therapeutics

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...